We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

The value of patience

8 October 2013 By Robert Cyran, Olaf Storbeck

Folding the German drug distributor into American rival McKesson would yield big savings. But Celesio has no CEO, is only in talks with McKesson and its controlling family is struggling and wants cash. Courting more buyers may bump up the price and put minority investors at ease.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)